CDXSCODEXIS, INC.

Nasdaq codexis.com


$ 3.92 $ 0.58 (17.37 %)    

Friday, 03-May-2024 15:59:28 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 3.92
$ 3.58
$ 3.91 x 100
$ 0.00 x 0
$ 3.58 - $ 4.00
$ 1.45 - $ 4.91
1,701,492
na
258.45M
$ 1.91
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-27-2023 12-31-2022 10-K
7 11-04-2022 09-30-2022 10-Q
8 08-05-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 02-28-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 03-01-2019 12-31-2018 10-K
23 11-09-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-15-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 03-09-2017 12-31-2016 10-K
31 11-08-2016 09-30-2016 10-Q
32 08-09-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 03-08-2016 12-31-2015 10-K
35 11-06-2015 09-30-2015 10-Q
36 08-11-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 03-06-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 benchmark-reiterates-buy-on-codexis-maintains-9-price-target

Benchmark analyst Robert Wasserman reiterates Codexis (NASDAQ:CDXS) with a Buy and maintains $9 price target.

 codexis-q1-2024-gaap-eps-016-beats-018-estimate-sales-17073m-beat-13660m-estimate

Codexis (NASDAQ:CDXS) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.18) by 11...

 benchmark-upgrades-codexis-to-buy-announces-9-price-target

Benchmark analyst Robert Wasserman upgrades Codexis (NASDAQ:CDXS) from Hold to Buy and announces $9 price target.

 recap-codexis-q4-earnings
Recap: Codexis Q4 Earnings
02/28/2024 21:35:36

 codexis-q4-2023-gaap-eps-010-beats-012-estimate-sales-2656m-beat-1990m-estimate

Codexis (NASDAQ:CDXS) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 16...

 earnings-scheduled-for-february-28-2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

 why-helix-energy-solutions-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

 codexis-secures-40m-in-strategic-financing-deal-with-innovatus-capital-partners-to-further-strengthen-cash-position-ahead-of-key-milestones

Term loan agreement enables Company to accelerate development and enhance commercialization of ECO Synthesis™ manufacturing pla...

 codexis-clinches-deal-with-nestl-health-science-eyes-up-to-45m-milestone-in-epi-treatment-breakthrough

Codexis, Inc. (NASDAQ: CDXS) entered a purchase deal with Nestlé S.A.(OTC: NSRGY) Nestlé Health Science for CDX-7108, a potenti...

 codexis-announces-purchase-agreement-with-nestl-health-science-for-cdx-7108--under-the-terms-codexis-will-receive-up-to-45m-in-potential-milestone-payments-including-a-5m-upfront-payment-as-well-as-single-digit-net-sales-based-royalties

Codexis, Inc. (NASDAQ:CDXS), a leading enzyme engineering company, today announced it has entered into a purchase agreement wit...

 why-amtech-systems-shares-are-trading-higher-by-over-30-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION